Clinical Trial: Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects
Study Status: Completed
Recruit Status: RECRUITING
Condition: FXI
Study Type: INTERVENTIONAL
Official Title: Single-center, Randomized, Double-blind, Placebo-controlled, Sequential Cohort Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAD of FXI-GalNAc-siRNA When Administer
Brief Summary:
The purpose of this study is to evaluate safety, tolerability, PK, and PD of SAD of FXI-GalNAc-siRNA administered SC to healthy subjects.
Read more